class="wp-theme-Newspaper supp-body td-standard-pack global-block-template-1 tdc-header-template tdc-footer-template td-animation-stack-type0 td-full-layout"
NO ESTABLISHED SAFE OR EFFECTIVE SUPPLEMENTAL DOSE. Gold nanoparticle accumulation in organs (liver, spleen, kidney). Chrysiasis: irreversible grey/blue skin discolouration with chronic gold accumulation. Pharmaceutical gold compounds (auranofin) cause significant adverse effects: proteinuria, thrombocytopenia, pulmonary toxicity. Drug interactions with other heavy metals and immunosuppressants. Potential genotoxicity of nanoparticles.
Colloidal suspension of gold nanoparticles (10-100nm) marketed for cognitive enhancement, anti-aging, arthritis, and immune modulation. No credible clinical evidence for any indication as a food supplement. Gold accumulates in tissues (chrysiasis). Gold compounds medically used only as prescription drugs (auranofin) for rheumatoid arthritis.
Acts on cellular signalling pathways relevant to the documented clinical indications. Contains bioactive compounds with enzyme-modulating, receptor-binding, or antioxidant properties studied in peer-reviewed literature.
| Population | Safety rating | Max safe dose |
|---|---|---|
| General | Possibly unsafe | — |
| Pregnancy | Possibly unsafe | — |
| Elderly | Possibly unsafe | — |
No peer-reviewed clinical trial data found for this ingredient.
Data by supplement.ge — Public Health Institute of Georgia (PHIG)